Practice Guideline
doi: 10.1016/j.tmrv.2007.01.004.
Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions
Affiliations
- PMID: 17397767
- DOI: 10.1016/j.tmrv.2007.01.004
Item in Clipboard
Practice Guideline
Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions
Transfus Med Rev.
2007 Apr.
Abstract
In Canada, intravenous immune globulin (IVIG) use has increased by 115% over the past 7 to 8 years. Given this increased usage, Canadian Blood Services and the National Advisory Committee on Blood and Blood Products for Canada identified the need to develop and disseminate evidence-based guidelines to facilitate appropriate IVIG use. As a result, guidelines for IVIG use in hematologic and neurologic conditions have been developed and are published in this supplement of Transfusion Medicine Reviews. This commentary provides a brief description of the process used to develop these guidelines and includes a summary of the recommendations for IVIG use in the various conditions evaluated.
Similar articles
-
Guidelines on the use of intravenous immune globulin for hematologic conditions.Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S9-56. doi: 10.1016/j.tmrv.2007.01.001. Transfus Med Rev. 2007. PMID: 17397769
-
Guidelines on the use of intravenous immune globulin for neurologic conditions.Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S57-107. doi: 10.1016/j.tmrv.2007.01.002. Transfus Med Rev. 2007. PMID: 17397768
-
Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions.Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S1-2. doi: 10.1016/j.tmrv.2007.01.003. Transfus Med Rev. 2007. PMID: 17397766 No abstract available.
-
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline.Transfus Med Rev. 2010 Jan;24 Suppl 1:S28-50. doi: 10.1016/j.tmrv.2009.09.011. Transfus Med Rev. 2010. PMID: 19962579 Review.
-
The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.Transfus Med Rev. 2010 Jan;24 Suppl 1:S7-S27. doi: 10.1016/j.tmrv.2009.09.010. Transfus Med Rev. 2010. PMID: 19962580 Review.
Cited by
-
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Ann Hematol. 2016 Sep;95(9):1435-55. doi: 10.1007/s00277-016-2711-1. Epub 2016 Jun 24. Ann Hematol. 2016. PMID: 27339055 Free PMC article.
-
Proteomics: applications in transfusion medicine.Blood Transfus. 2008 Apr;6(2):70-85. doi: 10.2450/2008.0038-07. Blood Transfus. 2008. PMID: 18946951 Free PMC article. Review. No abstract available.
-
Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.Clin Exp Immunol. 2009 Dec;158 Suppl 1(Suppl 1):23-33. doi: 10.1111/j.1365-2249.2009.04024.x. Clin Exp Immunol. 2009. PMID: 19883421 Free PMC article. Review.
-
Intravenous immunoglobulin in pediatrics: A review.Med J Armed Forces India. 2014 Jul;70(3):277-80. doi: 10.1016/j.mjafi.2013.05.011. Epub 2013 Aug 6. Med J Armed Forces India. 2014. PMID: 25378784 Free PMC article.
-
Polyvalent Immunoglobulin as a Potential Treatment Option for Patients with Recurrent COPD Exacerbations.Int J Chron Obstruct Pulmon Dis. 2021 Mar 2;16:545-552. doi: 10.2147/COPD.S283832. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33688179 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
